Overexpression of coxsackie and adenovirus receptor inhibit growth of human bladder cancer cell in vitro and in vivo

Acta Pharmacologica Sinica

Volumn 28, Issue 6, 2007, Pages 895-900

  Zhang, Lin Lin ^a   He, Da Lin ^a,b   Li, Xiang ^a   Li, Lei ^a   Zhu, Guo Dong ^a   Zhang, Dong ^a   Wang, Xin Yang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Bladder cancer; Cell growth; Coxsackie and the adenovirus receptor; Nude mice

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTIBIOTIC G 418; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; RETROVIRUS VECTOR; VIRUS DNA;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; BLADDER CANCER; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGEN TESTING; CELL CLONE; COLONY FORMING UNIT; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUDE MOUSE; PROTEIN EXPRESSION; RESTRICTION MAPPING; TARGET CELL; TUMOR VOLUME; VIRUS TITRATION; WESTERN BLOTTING; XENOGRAFT;

ANIMALS; CELL LINE; GENETIC VECTORS; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RECEPTORS, VIRUS; URINARY BLADDER NEOPLASMS;

EID: 34249289043     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00574.x     Document Type: Article

References (21)

1. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science, 1997 275 : 1320 3.
2. Tomko RP, Xu R, Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackie viruses. Proc Natl Acad Sci USA, 1997 94 : 3352 6.
3. Fechner H, Haack A, Wang H, Wang X, Eizema K, Pauschinger M, et al. Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers. Gene Ther, 1999 6 : 1520 35.
4. Li Y, Pong RC, Bergelson JM, Hall MC, Sagalowsky AI, Tseng CP, et al. Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. Cancer Res, 1999 59 : 325 30.
5. Coyne CB, Bergelson JM. CAR: a virus receptor within the tight junction. Adv Drug Deliv Rev, 2005 57 : 869 82.
6. Kim M, Sumerel LA, Belousova N, Lyons GR, Carey DE, Krasnykh V, et al. The coxsackie and adenovirus receptor acts as a tumour suppressor in malignant glioma cells. Br J Cancer, 2003 88 : 1411 6.
7. Anders M, Hansen R, Ding RX, Rauen KA, Bissell MJ, Korn WM. Disruption of 3D tissue integrity facilitates adenovirus infection by deregulating the coxsackievirus and adenovirus receptor. Proc Natl Acad Sci USA, 2003 100 : 1943 8.
8. Okegawa T, Li Y, Pong RC, Bergelson JM, Zhou J, Hsieh JT. The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy. Cancer Res, 2000 60 : 5031 6.
9. Miller AD, Chen F. Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry. J Virol, 1996 70 : 5564 71.
10. Bubenik J, Baresova M, Viklicky V, Jakoubkova J, Sainerova H, Donner J. Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen. Int J Cancer, 1973 11 : 765 73.
11. Lai YJ, Pong RC, McConnell JD, Hsieh JT. Surrogate marker for predicting the virus binding of urogenital cancer cells during adenovirus-based gene therapy. Biotechniques, 2003 35 : 186 94.
12. Bodine DM, McDonagh KT, Brandt SJ, Ney PA, Agricola B, Byrne E, et al. Development of a high-titer retrovirus producer cell line capable of gene transfer into rhesus monkey hematopoietic stem cells. Proc Natl Acad Sci USA, 1990 87 : 3738 42.
13. Li L, He DL. Transfection of promyelocytic leukemia in retro-virus vector inhibits growth of human bladder cancer cells. Acta Pharmacol Sin, 2005 26 : 610 5.
14. Guo QL, You QD, Wu ZQ, Yuan ST, Zhao L. General gambogic acids inhibited growth of human hepatoma SMMC-7721 cells in vitro and in nude mice. Acta Pharmacol Sin, 2004 25 : 769 74.
15. Cohen CJ, Shieh JT, Pickles RJ, Okegawa T, Hsieh JT, Bergelson JM. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc Natl Acad Sci USA, 2001 98 : 15 191 6.
16. Okegawa T, Pong RC, Li Y, Bergelson JM, Sagalowsky AI, Hsieh JT. The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of car protein structure. Cancer Res, 2001 61 : 6592 600.
17. Sachs MD, Rauen KA, Ramamurthy M, Dodson JL, De Marzo AM, Putzi MJ, et al. Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer. Urology, 2002 60 : 531 6.
18. Dmitriev I, Krasnykh V, Miller CR, Wang M, Kashentseva E, Mikheeva G, et al. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackie and adenovirus receptor-independent cell entry mechanism. J Virol, 1998 72 : 9706 13.
19. Hemmi S, Geertsen R, Mezzacasa A, Peter I, Dummer R. The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures. Hum Gene Ther, 1998 9 : 2363 73.
20. Li D, Duan L, Freimuth P, O'Malley BW Jr. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer. Clin Cancer Res, 1999 5 : 4175 81.
21. Qin M, Escuadro B, Dohadwala M, Sharma S, Batra RK. A novel role for the coxsackie adenovirus receptor in mediating tumor formation by lung cancer cells. Cancer Res, 2004 64 : 6377 80.